HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1.
Kumagai T, Tomita Y, Nakatsuka SI, Kimura M, Kunimasa K, Inoue T, Tamiya M, Nishino K, Susaki Y, Kusu T, Tokunaga T, Okami J, Higashiyama M, Imamura F.
Kumagai T, et al. Among authors: kimura m.
Thorac Cancer. 2018 Apr;9(4):466-471. doi: 10.1111/1759-7714.12609. Epub 2018 Feb 23.
Thorac Cancer. 2018.
PMID: 29473311
Free PMC article.